Circulating markers of biliary malignancy: opportunities in proteomics? (Q37073078)

18 August 2017

1 reference

title

Circulating markers of biliary malignancy: opportunities in proteomics? (English)

1 reference

Rosamonde Elizabeth Banks

18 August 2017

5

Peter J Selby

0 references

6

object named as

Rosamonde E Banks

0 references

Glenn Kunnath Bonney

object named as

Glenn K Bonney

1

0 references

author name string

Rachel A Craven

2

1 reference

18 August 2017

Raj Prasad

3

1 reference

18 August 2017

Alan F Melcher

4

1 reference

18 August 2017

publication date

1 February 2008

1 reference

Lancet Oncology Commission

18 August 2017

published in

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

149-158

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

18 August 2017

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

1 reference

7 January 2021

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Current approaches to the diagnosis and treatment of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Primary sclerosing cholangitis and cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Primary sclerosing cholangitis: summary of a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Liver transplantation for unresectable perihilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Cholangiocyte biology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases o

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

CEACAM6 gene expression in intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Serum and bile markers for cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Serum MUC5AC mucin as a potential marker for cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

A proteomic analysis of human bile

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteome informatics I: bioinformatics tools for processing experimental data.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Current two-dimensional electrophoresis technology for proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Mass spectrometry-based proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteomic patterns of tumour subsets in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

The human plasma proteome: a nonredundant list developed by combination of four separate sources

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Cholangiocyte-specific rat liver proteins identified by establishment of a two-dimensional gel protein database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteomic analysis of cholangiocarcinoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteomic analysis of livers of patients with primary hepatolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Identification and distribution of proteins in isolated endosomal fractions of rat liver: involvement in endocytosis, recycling and transcytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Two-dimensional electrophoretic analysis of vesicular and micellar proteins of gallbladder bile

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Isolation and characterization of hydrophobic polypeptides in human bile

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

The proteins and the formation of gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Proteomic characterization of metabolites, protein adducts, and biliary proteins in rats exposed to 1,1-dichloroethylene or diclofenac

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970027-5

7 January 2021

10.1016/S1470-2045(08)70027-5

Identifiers

DOI

1 reference

18 August 2017

1 reference